Cytotoxicity of 2,2':6',2-terpyridineplatinum(II) complexes against human ovarian carcinoma

Journal of Medicinal Chemistry

Volumn 42, Issue 16, 1999, Pages 3167-3174

  Lowe, Gordon ^a   Droz, Anne Sophie ^a   Vilaivan, Tirayut ^a   Weaver, George W ^a   Park, Jenny J ^a   Pratt, Jonathan M ^a   Tweedale, Lindsay ^a   Kelland, Lloyd R ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; PLATINUM COMPLEX; PYRIDINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; OVARY CARCINOMA; REACTION ANALYSIS;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0033549848     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm991053y     Document Type: Article

References (27)

1. Jennette, K.; Lippard, S. J.; Vassiliades, G.; Bauer, W. Metallointercalation Reagents. 2-Hydroxyethanethiolato(2,2′,2″-terpyridine)-platinuni (II) monocation binds strongly to DNA by Intercalation. Proc. Natl. Acad. Sci. U.S.A. 1974, 71, 3839-3843.
2. McCoubrey, A.; Latham, H. C.; Cook, P. R.; Rodger, A.; Lowe, G. 4-Picoline 2,2′:6′,2″-terpyridine-platinum (II) - a Potent Intercalator of DNA. FEBS Lett. 1996, 380, 73-78.
3. Lowe, G.; McCloskey, J.; Ni, J.; Vilaivan, T. A Mass Spectroscopic Investigation of the Reaction between 4,4′-Vinylenedipyridine Bis[2,2′:6′,2″-terpyridine-platinum (II)] and the Self-complementary Oligonucleotide d(CpGpTpApCpG). Bioorganic Med. Chem. 1996, 4, 1007-1013.
4. Lowe, G.; Hartley, J.; et al. Unpublished work.
5. Lowe, G.; Vilaivan, T. An improved method for the synthesis of 2,2′:6′,2″-terpyridine-platinum (II) complexes. J. Chem. Res. (S) 1996, 386-387.
6. Case, F. H.; Kaspen, T. J. The Preparation of some Substituted 2,6-Bis-(2-pyridyl)-pyridines. J. Am. Chem. Soc. 1956, 78, 5842.
7. Spahni, W.; Calzaferri, G. Synthese von para-substituierten Phenyl-Terpyridin Liganden. Helv. Chim. Acta 1984, 67, 450-453.
8. Collin, J.-P.; Guillerez, S.; Sauvage, J.-P.; Barigelletti, F.; De Cola, L.; Flamigni, L.; Balzani, V. Photoinduced Processes in Dyads and Triads Containing a Ruthenium (II)-Bis(terpyridine) Photosensitizer Covalently Linked to Electron Donor and Acceptor Groups. Inorg. Chem. 1991, 30, 4230-4238.
9. Constable, E. C.; Cargill Thompson, A. M. W.; Tocher, D. A.; Daniels, M. A. M. Synthesis, Characterisation and Spectroscopic Properties of Ruthenium(II)-2,2′:6′,2″-terpyridine Coordination Triades. X-ray structure of 4′-(N,N-Dimethylamino)-2,2′:6′,2″-terpyridine and Bis(4′-(N,N-Dimethylamino)-2,2′:6′,2″-terpyridine)- ruthenium(II) Hexafluorophosphate Acetonitrile Solvate. New J. Chem. 1992, 16, 855-867.
10. Howe-Grant, M.; Wu, K. C.; Bauer, W. R.; Lippard, S. J. Binding of Platinum and Palladium Metallointercalation Reagents and Antitumour Drugs to Closed and Open DNAs. Biochemistry 1976, 15, 4339-4346.
11. Peyratout, C. S.; Aldridge, T. K.; Crites, D. K.; McMillin, D. R. DNA-Binding Studies of a Bifunctional Platinum Complex that is a Luminescent Intercalator. Inorg. Chem. 1994, 34, 4484-4489.
12. Kelland, L. R.; Mistry, P.; Abel, G.; Loh, S. Y.; O'Neill, C. F.; Murrer, B. A.; Harrap, K. R. Mechanism-related circumvention of cis-diamminedichloroplatinum(II) acquired resistance using two pairs of human ovarian cancer cell lines by ammine/amine platinum(IV) dicarboxylates. Cancer Res. 1992, 52, 3857-3864.
13. O'Neill, C. F.; Orr, R. M.; Kelland, L. R.; Harrap, K. R. Comparison of platinum (Pt) binding to DNA and removal of total Pt adducts and interstrand cross-links in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin. Cell Pharmacol. 1995, 2, 1-7.
14. Behrens, B. C.; Hamilton, T. C.; Masuda, H.; Grotsinger, K. R.; Whang-Peng, J.; Louie, K. G.; Knutsen, T.; McKoy, W. M.; Young, R. C.; Ozols, R. F. Charcterisation of cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cell line and its use in evaluation of platinum analogues. Cancer Res. 1987, 47, 414-418.
15. Johnson, S. W.; Perez, R. P.; Godwin, A. K.; Yeung, A. T.; Handel, L. M.; Ozols, R. F.; Hamilton, T. C. Role of platinum-DNA adduct formation and removal in cisplatin resistace in human ovarian cancer cell lines. Biochem. Pharmacol. 1994, 47, 689-697.
16. Kelland, L. R.; Barnard, C. F. J.; Mellish, K. J.; Jones, M.; Goddard, P. M.; Valenti, M.; Murrer, B. A.; Harrap, K. R. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumour activity. Cancer Res. 1994, 54, 5618-5622.
17. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J.; Bokesch, H.; Kennedy, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
18. ICON Collaborators. ICON 2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer. Lancet 1998, 352, 1571-1576.
19. Chernega, A.; Droz, A. S.; Prout, K.; Vilaivan, T.; Weaver, G. W.; Lowe, G. Structural Evidence for the Reactivity of 4-Picoline 2,2′:6′,2″-terpyridine (II) Complexes and Evidence for π-stacking in the Crystal Lattice. J. Chem. Res. (S) 1996, 402-403.
20. Blackburn, G. M.; Gait, M. J. Nucleic Acids in Chemistry and Biology, 2nd ed.; IRL Press: Oxford University, 1996; pp 352-357.
21. Holford, J.; Sharp, S. Y.; Murrer, B. A.; Abrams, M.; Kelland, L. R. In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473. Br. J. Cancer 1998, 77, 366-373.
22. Kelland, L. R.; Abel, G.; McKeage, M. J.; Jones, M.; Goddard, P. M.; Valenti, M.; Murrer, B. A.; Harrap, K. R. Preclinical antitumour evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum (IV), an orally active platinum drug. Cancer Res. 1993, 53, 2581-2586.
23. Constable, E. C.; Ward, M. D. Synthesis and Coordination Behaviour of 6′,6″-Bis(2-pyridyl)-2,2′:4,4″:2″,2‴- quaterpyridine; 'Back-to-back' 2,2′:6′,2″-Terpyridine. J. Chem. Soc., Dalton Trans. 1990, 1405-1409.
24. 2+. Nouv. J. Chim. 1983, 7, 413-420.
25. Lowe, G.; Droz, A S.; Vilaivan, T.; Weaver, G. W.; Tweedale, L.; Pratt, J. M.; Rock, P.; Yardley, V.; Croft, S. L. Cytotoxicity of 2,2′:6′,2″-Terpyridine Pt(II) Complexes to Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. J. Med. Chem. 1999, 42, 999-1006.
26. Della Ciana, L.; Haim, A. Synthesis of 1,4-Bis(4-pyridyl)-butadiyne. J. Heterocyl. Chem. 1984, 21, 607-608.
27. Takahashi, S.; Kuroyama, Y.; Sonogashira, K.; Hagihara, N. A Convenient Synthesis of Ethynylarenes and Diethynylarenes. Synthesis 1980, 8, 627-630.